211 related articles for article (PubMed ID: 24349380)
1. Metabolomics of the tumor microenvironment in pediatric acute lymphoblastic leukemia.
Tiziani S; Kang Y; Harjanto R; Axelrod J; Piermarocchi C; Roberts W; Paternostro G
PLoS One; 2013; 8(12):e82859. PubMed ID: 24349380
[TBL] [Abstract][Full Text] [Related]
2. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
3. Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin-Frankfurt-Münster-based induction therapy for childhood acute lymphoblastic leukemia.
Steiner M; Hochreiter D; Kasper DC; Kornmüller R; Pichler H; Haas OA; Pötschger U; Hutter C; Dworzak MN; Mann G; Attarbaschi A
Leuk Lymphoma; 2012 Sep; 53(9):1682-7. PubMed ID: 22356135
[TBL] [Abstract][Full Text] [Related]
4. No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy.
Tong WH; Pieters R; Hop WC; Lanvers-Kaminsky C; Boos J; van der Sluis IM
Pediatr Blood Cancer; 2013 Feb; 60(2):258-61. PubMed ID: 22961784
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow recovery of hematopoietic stem cells and microenvironment after chemotherapy in childhood acute lymphoblastic leukemia: consecutive observations according to chemotherapy schedule.
Park SH; Lee MJ; Park CJ; Jang S; Seo EJ; Im HJ; Seo JJ
Pediatr Hematol Oncol; 2019 May; 36(4):222-235. PubMed ID: 31313940
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia.
Schraw JM; Woodhouse JP; Bernhardt MB; Taylor OA; Horton TM; Scheurer ME; Okcu MF; Rabin KR; Lupo PJ; Brown AL
Sci Rep; 2021 Oct; 11(1):19613. PubMed ID: 34608220
[TBL] [Abstract][Full Text] [Related]
8. Low IL-23 levels in peripheral blood and bone marrow at diagnosis of acute leukemia in children increased with the elimination of leukemic burden.
Zampogiannis A; Piperi C; Baka M; Zoi I; Papavassiliou AG; Moschovi M
J Cell Mol Med; 2021 Aug; 25(15):7426-7435. PubMed ID: 34235838
[TBL] [Abstract][Full Text] [Related]
9. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
[TBL] [Abstract][Full Text] [Related]
10. The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.
Dander E; Palmi C; D'Amico G; Cazzaniga G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922612
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
[TBL] [Abstract][Full Text] [Related]
12. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
Boyerinas B; Zafrir M; Yesilkanal AE; Price TT; Hyjek EM; Sipkins DA
Blood; 2013 Jun; 121(24):4821-31. PubMed ID: 23589674
[TBL] [Abstract][Full Text] [Related]
13. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
14. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Wu S; Korte A; Gessner R; Henze G; Seeger K
Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
[TBL] [Abstract][Full Text] [Related]
15. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study.
Kushwaha R; Kumar A; Aggrawal K; Nigam N; Kumar A
Indian J Pathol Microbiol; 2014; 57(1):72-7. PubMed ID: 24739836
[TBL] [Abstract][Full Text] [Related]
16. Biological Features of Bone Marrow Mesenchymal Stromal Cells in Childhood Acute Lymphoblastic Leukemia.
Genitsari S; Stiakaki E; Perdikogianni C; Martimianaki G; Pelagiadis I; Pesmatzoglou M; Kalmanti M; Dimitriou H
Turk J Haematol; 2018 Mar; 35(1):19-26. PubMed ID: 28884706
[TBL] [Abstract][Full Text] [Related]
17. Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study.
Chowdhury S; Bandyopadhyay S; Mandal C; Chandra S; Mandal C
BMC Cancer; 2008 Feb; 8():40. PubMed ID: 18241334
[TBL] [Abstract][Full Text] [Related]
18. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
[TBL] [Abstract][Full Text] [Related]
19. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
